Bacopa monnieri vs Selank
Side-by-side comparison of Bacopa monnieri and Selank: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Bacopa monnieri
Selank
Bacopa monnieri
Bacopa monnieri is a creeping, succulent-leaved aquatic perennial that grows in wetlands, bogs, and rice paddies across the Indian subcontinent, Southeast Asia, northern Australia, and the southern United States. Known…
No vendor price on file.
Full Bacopa monnieri profileSelank
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, 750 Da molecular weight) developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences as a synthetic analog of tuftsin…
Lowest listed price: $25.00 across 6 listings
Full Selank profileSide-by-side comparison
| Attribute | Bacopa monnieri | Selank |
|---|---|---|
| Category | Nootropic Adaptogen | Nootropics |
| Research Stage | Preclinical | Approved (Russia, as anxiolytic and nootropic medication) |
| Mechanism of Action | Bacopa monnieri's cognitive effects emerge from at least six convergent molecular mechanisms that span neurotransmitter modulation, trophic-factor expression, structural plasticity, antioxidant defense, vascular regulation, and receptor-level anxiolysis. No… | Primary Mechanism: Multi-System Neurochemical Modulation Selank does not have a single clean receptor-binding mechanism. Unlike benzodiazepines (GABA-A positive allosteric modulators), SSRIs (serotonin reuptake inhibition), or buspirone (5-HT1A partial… |
| Half-Life | — | ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation) |
| Typical Dose Range | — | 250-750 mcg intranasal daily (0.15% solution: 2-3 drops per nostril 2-3x daily); typical course is 14-21 days |
| Dosing Frequency | — | Intranasal 1–3 times daily |
| Administration | — | Intranasal |
| Side Effects | Bacopa monnieri's side-effect profile is dominated by gastrointestinal symptoms, which occur in 20-30% of users at therapeutic doses and represent the primary reason users discontinue the compound. Mechanistically, the GI effects appear to reflect Bacopa's… | Overall Safety Profile Selank has one of the best safety profiles in the anxiolytic space. Over 15+ years of Russian clinical use and research, the compound has been associated with essentially no serious adverse events at therapeutic doses. This compares… |
| Molecular Weight | — | 751.9 Da |
| Common Vial Sizes | — | 5mg, 10mg |
Price History
5 data points- OF
- Half Nattys
- Ion Peptide
- BHG Labs
Bacopa monnieri: potential benefits
- No structured benefit list published.
Selank: potential benefits
- Anxiolytic effects comparable to benzodiazepines but without sedation or dependence in Russian clinical trials (PMID: 18454096)
- Positive allosteric modulation of brain GABA receptors through a non-benzodiazepine binding site (PMID: 30255741)
- Immunomodulation via Th1/Th2 cytokine balance and IL-6 regulation in patients with anxiety-asthenic disorders (PMID: 18577961)
- Cognitive and memory support linked to BDNF upregulation in the hippocampus in preclinical models (PMID: 18841804)
- Modulation of the endogenous enkephalin-opioid system supporting mood and stress tolerance (PMID: 22550852)
- Anti-inflammatory and adaptogenic effects through normalization of stress-induced cytokine dysregulation
- Non-addictive anxiolytic profile - no tolerance, withdrawal, or dependence reported across years of Russian clinical use
Frequently asked
What's the difference between Bacopa monnieri and Selank?
Bacopa monnieri is a nootropic adaptogen that bacopa monnieri's cognitive effects emerge from at least six convergent molecular mechanisms that span neurotransmitter modulation, trophic-factor expression, structural…. Selank is a nootropics that primary mechanism: multi-system neurochemical modulation selank does not have a single clean receptor-binding mechanism. unlike benzodiazepines (gaba-a positive allosteric…. The two differ in mechanism, half-life (not reported vs ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation)), and typical dose range.
Which has the longer half-life, Bacopa monnieri or Selank?
Bacopa monnieri has a half-life of not reported. Selank has a half-life of ~2-3 minutes plasma half-life (functional anxiolytic and nootropic effects persist 12-24 hours due to gene expression and neurotransmitter modulation). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Bacopa monnieri and Selank?
Stacking depends on mechanism overlap, safety profile, and goals. Bacopa monnieri and Selank should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Bacopa monnieri or Selank
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.